“PRP is cementing its place in the symptomatic treatment of early knee OA.”
ABSTRACT: Platelet rich plasma (PRP) has clearly emerged offering a possible solution that could modify the disease process and offer symptomatic relief in early osteoarthritis of knee. Great efforts are underway to improve PRP products for use in knee osteoarthritis (OA). Upcoming research is focused on the ideal PRP type, dose, frequency of injection and mode of injection. The combination of PRP with biocompatible carriers/scaffolds like gelatin hydrogel and chitosan appear to be promising based on early in vitro and animal studies. PRP in combination with hyaluronate has also emerged to have synergistic and additive effects. This article intends to review the recent trends and advancing ideas for improvising PRP for use in early knee OA treatment.
CONCLUSION: PRP is cementing its place in the systomatic treatment of early knee OA. It is clear that all PRP products are not the same and hence more research into defining the ideal PRP preparation, dose, con-centration, number of injections, activation status and if PRP should be ideally combined with other substances and/or engineered biomaterials. The common aim is improving the present day PRP to make it more effective, compliant and long acting for the treatment of early knee OA.